Phibro Animal Health Corporation (PAHC)

Currency in USD
34.29
-1.21(-3.41%)
Closed·
34.290.00(0.00%)
·

PAHC Earnings

Latest Release
May 06, 2026
EPS / Forecast
0.76 / 0.71
Revenue / Forecast
383.5M / 365.2M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/06--/0.719--/382.51M----Free Sign Up
2026/030.760/0.710383.50M/365.20M+7.04%+5.01%Free Sign Up
2025/120.870/0.680373.90M/355.24M+27.94%+5.25%Free Sign Up
2025/090.730/0.600363.90M/345.44M+21.67%+5.34%Free Sign Up
2025/060.570/0.520378.70M/362.24M+9.62%+4.54%Free Sign Up
2025/030.630/0.530347.80M/309.50M+18.87%+12.37%Free Sign Up
2024/120.540/0.430309.30M/287.13M+25.58%+7.72%Free Sign Up
2024/090.350/0.250260.40M/246.60M+40%+5.6%Free Sign Up
2024/060.410/0.330273.20M/260.49M+24.24%+4.88%Free Sign Up
2024/030.310/0.290263.20M/251.16M+6.9%+4.79%Free Sign Up

All numbers in USD

Phibro Animal Health Corporation Earnings Call Summary for Q3/2026

  • Q3 FY2026 EPS of $0.76 beat forecast of $0.71; revenue of $383.5M exceeded expectations by 5%, driven by 13% Animal Health segment growth.
  • Stock plummeted 23% in after-hours trading to $43.16 despite earnings beat, closing at $36.58 near 52-week low of $22.51.
  • Launched VERRATAIN sustainable solutions platform; Animal Health segment contributed $291.2M while Performance Products declined 17%.
  • FY2026 EPS guidance of $3.1 and revenue forecast of $1.497B; FY2027 projections at $3.45 EPS and $1.55B revenue.
  • Brazilian regulatory changes on antimicrobials pose challenges; adjusted EBITDA rose 11% to $60M with $77.5M cash on hand.
Last Updated: 2026-05-13, 01:42 p/m
Read Full Transcript

FAQ

What Is Phibro's Earnings Per Share (TTM)?

The Phibro EPS (TTM) is 2.33.

When Is The Next Phibro Earnings Date?

Phibro will release its next earnings report on Sep 02, 2026.

What Is Phibro’s Revenue Forecasts For Upcoming Quarters?

Phibro’s revenue forecast is 382.51M.

How Did Phibro React to the Company's Latest Earnings Report?

Phibro reported a +7.04% EPS surprise and a +5.01% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -23.26%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.